365 related articles for article (PubMed ID: 3128677)
1. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
Hotta N; Sakamoto N
Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
[No Abstract] [Full Text] [Related]
2. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
Kador PF; Kinoshita JH; Sharpless NE
J Med Chem; 1985 Jul; 28(7):841-9. PubMed ID: 3925146
[No Abstract] [Full Text] [Related]
3. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
Jacobson M; Sharma YR; Cotlier E; Hollander JD
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
[TBL] [Abstract][Full Text] [Related]
4. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
Christensen JE; Larsen AB; Gregersen G
Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
[No Abstract] [Full Text] [Related]
5. Aldose reductase inhibitors and diabetic complications.
Raskin P; Rosenstock J
Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
[No Abstract] [Full Text] [Related]
6. Aldose reductase inhibitors and the complications of diabetes mellitus.
Tomlinson DR
Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
[No Abstract] [Full Text] [Related]
7. Aldose reductase inhibitors.
Kirchain WR; Rendell MS
Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase inhibition for diabetic neuropathy.
Lancet; 1983 Oct; 2(8356):969. PubMed ID: 6138528
[No Abstract] [Full Text] [Related]
9. Aldose reductase inhibitors and diabetic complications.
Tomlinson DR; Willars GB; Carrington AL
Pharmacol Ther; 1992; 54(2):151-94. PubMed ID: 1438531
[TBL] [Abstract][Full Text] [Related]
10. The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study.
Christensen JE; Varnek L; Gregersen G
Acta Neurol Scand; 1985 Feb; 71(2):164-7. PubMed ID: 3920861
[TBL] [Abstract][Full Text] [Related]
11. Medical therapy in the prevention of cataract.
Brown NA; Bron AJ
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():748-54. PubMed ID: 3938085
[TBL] [Abstract][Full Text] [Related]
12. The pharmacology of aldose reductase inhibitors.
Kador PF; Robison WG; Kinoshita JH
Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
[No Abstract] [Full Text] [Related]
13. [Aldose reductase inhibitors in diabetic neuropathy].
Erkelens DW; Bravenboer B
Ned Tijdschr Geneeskd; 1990 Apr; 134(15):775-6. PubMed ID: 2110629
[No Abstract] [Full Text] [Related]
14. Aldose reductase in diabetic cataracts.
Kinoshita JH; Kador P; Catiles M
JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
[No Abstract] [Full Text] [Related]
15. The polyol pathway in retinal microangiopathy.
Robison WG; Kinoshita JH; Kador PF
Drugs; 1986; 32 Suppl 2():19-22. PubMed ID: 3098542
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase inhibitors and late complications of diabetes.
Benfield P
Drugs; 1986; 32 Suppl 2():43-55. PubMed ID: 3098544
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of pericyte ghost formation in retinal capillaries by aldose reductase inhibitor in galactose-fed dogs with diabetic retinopathy].
Akagi Y; Terubayashi H; Ikebe H; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1479-84. PubMed ID: 3145681
[No Abstract] [Full Text] [Related]
18. Aldose reductase inhibitors in clinical practice. Preliminary studies on diabetic neuropathy and retinopathy.
Pitts NE; Gundersen K; Mehta DJ; Vreeland F; Shaw GL; Peterson MJ; Collier J
Drugs; 1986; 32 Suppl 2():30-5. PubMed ID: 3098543
[TBL] [Abstract][Full Text] [Related]
19. The effects of sorbinil on the pathophysiology of diabetic complications. Proceedings of a symposium. Dorado, Puerto Rico, May 30-June 2, 1985.
Metabolism; 1986 Apr; 35(4 Suppl 1):1-121. PubMed ID: 3083196
[No Abstract] [Full Text] [Related]
20. Aldose reductase inhibition. The chemical key to the control of diabetic retinopathy?
Frank RN
Arch Ophthalmol; 1990 Sep; 108(9):1229-31. PubMed ID: 2119167
[No Abstract] [Full Text] [Related]
[Next] [New Search]
